Exova Diagnostics (ExovaDx) Laboratory is a high complexity clinical lab in El Paso TX. The lab is a CLIA and COLA Accredited Diagnostic Laboratory focusing on Molecular Diagnostics. It is one of the affiliated laboratories to Nova labs LLC. of California. The lab runs multiple qualitative and quantitative molecular diagnostics test including molecular infectious and molecular oncology assays.
ExovaDx has proven itself an indispensable COVID-19 testing partner to state, county, and city agencies throughout the United States. With the current pandemic, the company modified their high-throughput high complex laboratory to be able to serve the national need of SARS-CoV-2 testing. The lab launched their first COVID-19 program in town starting March 2021. The lab runs different multi-target COVID-19 molecular diagnostics tests that are used to screen and detect the presence of the virus that causes COVID-19 (SARS-CoV-2) in upper and lower respiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, tracheal aspirates, bronchoalveolar lavage, and saliva) utilizing the Food and Drug Administration (FDA) authorized 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse transcription-polymerase chain reaction (RT-PCR) Diagnostic Panels for testing. To date, ExovaDx has collected, transported, tested, and resulted thousands of COVID-19 tests. Exova Diagnostics provide simple and straightforward results and can safely process and accurately report 10,000 PCR tests per day.
ExovaDx lab as a provider of advanced anatomic pathology services is specialized on diagnosing upper and lower extremity neuropathic disease and nerve damage. The neurologic diagnostic test offerings include Epidermal Nerve Fiber Density (ENFD) analysis and molecular genetics to detect and identify micro-organisms to diagnose and guide treatment decisions. ExovaDx has in-network billing services, including all five national health plans, state-specific Medicaid, Preferred Provider Organization (PPO), Health Maintenance Organization (HMO), and marketplace plans, and fully compliant patient-friendly billing policies.